Modeling undetected poliovirus circulation following the 2022 outbreak in the United States

Modeling undetected poliovirus circulation following the 2022 outbreak in the United States

ABSTRACTBackground New York State (NYS) reported a polio case (June 2022) and outbreak of imported type 2 circulating vaccine-derived poliovirus (cVDPV2) (last positive wastewater detection in February 2023), for which uncertainty remains about potential ongoing undetected transmission.Research Desi...

Full description

Bibliographic Details
Main Authors:	Dominika A. Kalkowska, Kamran Badizadegan, Janell A. Routh, Cara C. Burns, Eli S. Rosenberg, I. Ravi Brenner, Jane R. Zucker, Marisa Langdon-Embry, Kimberly M. Thompson
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Expert Review of Vaccines
Subjects:	Polio eradication dynamic modeling outbreak response IPV
Online Access:	https://www.tandfonline.com/doi/10.1080/14760584.2023.2299401

Similar Items

Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation
by: Kimberly M. Thompson, et al.
Published: (2023-03-01)

Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation [version 1; peer review: 1 approved, 2 approved with reservations]
by: Steven GF Wassilak, et al.
Published: (2023-04-01)

Oral polio vaccine stockpile modeling: insights from recent experience
by: Kimberly M. Thompson, et al.
Published: (2023-12-01)

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine
by: Radboud J. Duintjer Tebbens, et al.
Published: (2018-08-01)

Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV)
by: Kimberly M. Thompson, et al.
Published: (2019-07-01)

Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance
by: Roland W. Sutter, et al.
Published: (2024-03-01)

Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative [version 1; peer review: 2 approved]
by: Kimberly M. Thompson, et al.
Published: (2022-02-01)

Poliovirus vaccination during the endgame: insights from integrated modeling
by: Radboud J. Duintjer Tebbens, et al.
Published: (2017-06-01)

Environmental Surveillance for Polioviruses in Haïti (2017–2019): The Dynamic Process for the Establishment and Monitoring of Sampling Sites
by: Mary M. Alleman, et al.
Published: (2021-03-01)

The Distribution of the Acute Flask Paralysis and Isolated Polioviruses in Polio Eradication Programme in Turkey in 1999 (January-October)
by: Etem ÖZKAYA, et al.
Published: (2000-06-01)

Uso universal da vacina inativada contra poliomielite Universal use of inactivated polio vaccine
by: Luiza Helena Falleiros Carvalho, et al.
Published: (2006-07-01)

Epidemiological Surveillance of Acute Flaccid Paralysis for Eradication of Poliomyelitis (A Brief Review)
by: Simeonova I., et al.
Published: (2024-03-01)

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 3; peer review: 2 approved, 1 approved with reservations]
by: Megan Auzenbergs, et al.
Published: (2023-04-01)

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 2; peer review: 2 approved, 1 approved with reservations]
by: Megan Auzenbergs, et al.
Published: (2022-05-01)

The impact of surveillance and other factors on detection of emergent and circulating vaccine derived polioviruses [version 1; peer review: 2 approved, 1 approved with reservations]
by: Megan Auzenbergs, et al.
Published: (2021-06-01)

Vaccine-Derived Polioviruses, Central African Republic, 2019
by: Marie-Line Joffret, et al.
Published: (2021-02-01)

Last fight of wild polio in Africa: Nigeria’s battle
by: Yusuff Adebayo Adebisi, et al.
Published: (2020-11-01)

Polio eradication: Current status and challenges
by: Soumyadeep Bhaumik
Published: (2012-01-01)

Vaccine-derived poliovirus surveillance in China during 2001–2013: the potential challenge for maintaining polio free status
by: Hai-Bo Wang, et al.
Published: (2017-12-01)

Immunogenicity of a combined schedule of trivalent oral and inactivated polio vaccines in South African infants
by: Shelina Moonsamy, et al.
Published: (2019-07-01)

Lessons from Vaccine-Related Poliovirus in Israel, UK and USA
by: T. Jacob John, et al.
Published: (2022-11-01)

Distribution pattern of poliovirus potentially infectious materials in the phase 1b medical laboratories containment in conformity with the global action plan III
by: Bassey Enya Bassey, et al.
Published: (2018-12-01)

Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in Pakistan
by: Laina D. Mercer, et al.
Published: (2017-10-01)

ACUTE FLACCID PARALYSIS REGISTERED FOR THE PERIOD 2012-2020, IN STARA ZAGORA REGION
by: I. Simeonova, et al.
Published: (2021-06-01)

Eradikasi Polio
by: Hindra Irawan Satari, et al.
Published: (2017-01-01)

Vaccine-Derived Polioviruses Not Detected by Global Surveillance Screening Assay
by: Deepa K. Sharma, et al.
Published: (2015-10-01)

PROSPECTIVES AND NECESSITY OF ERADICATION OF INFECTIOUS BOVINE RHINOTRACHEITIS / INFECTIOUS PUSTULAR VULVOVAGINITIS IN THE REPUBLIC OF SERBIA
by: Sava Lazić, et al.
Published: (2016-11-01)

Polio eradication in Pakistan: Hope against hope or are we near eradication?
by: Tauseef Ahmad, et al.
Published: (2024-03-01)

Trends of key surveillance performance indicators of acute flaccid paralysis: a descriptive analysis, Uganda, 2015–2020
by: Bob Omoda Amodan, et al.
Published: (2022-09-01)

Dynamics affecting the risk of silent circulation when oral polio vaccination is stopped
by: J.S. Koopman, et al.
Published: (2017-09-01)

Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan
by: Muhammad Atif Habib, et al.
Published: (2023-09-01)

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry
by: Grace Macklin, et al.
Published: (2017-09-01)

Population Immunity and Polio Eradication
by: Paul E. M. Fine
Published: (2024-02-01)

Evaluation of 17 years of MERIN (Meningitis and Encephalitis register in Lower Saxony, Germany) surveillance system: participants acceptability survey, completeness and timeliness of data
by: Anna Łuczyńska, et al.
Published: (2024-01-01)

The influence of gender dynamics on polio eradication efforts at the community, workplace, and organizational level
by: Anna Kalbarczyk, et al.
Published: (2021-06-01)

Application of ultrafiltration membranes for purification and concentration of Sabin poliovirus type 1
by: A. A. Kovpak, et al.
Published: (2021-05-01)

Malawi polio outbreak: What next?
by: Isabel Kazanga‐Chiumia, et al.
Published: (2022-09-01)

Development of an animal component free production process for Sabin inactivated polio vaccine
by: Diego A. Suarez-Zuluaga, et al.
Published: (2022-12-01)

The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases
by: Kouichi Kitamura, et al.
Published: (2021-07-01)

Polio Eradication–Lessons from the Past and Future Perspective
by: Swati Jain, et al.
Published: (2014-07-01)